Xilio Therapeutics, Inc.

📍 Waltham, United States🗓 Founded 2016👥 71 employees💰 Last funded Jun 2024
Biotechnology Research🌐 xiliotx.com
Website LinkedIn
Xilio is a Waltham, Massachusetts-based clinical-stage biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer.
2
Total investors
0
Early stage
1
Mid stage
1
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography2 countries
Netherlands
1
United States
1
Frequently asked questions
Who invested in Xilio Therapeutics, Inc.?
Xilio Therapeutics, Inc. has 2 investors on record on gritt.io, 1 mid-stage and 1 late-stage investors.
When did Xilio Therapeutics, Inc. last raise funding?
The most recent investment in Xilio Therapeutics, Inc. recorded on gritt.io was in June 2024.
When was Xilio Therapeutics, Inc. founded?
Xilio Therapeutics, Inc. was founded in 2016.
What industry is Xilio Therapeutics, Inc. in?
Xilio Therapeutics, Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Xilio Therapeutics, Inc. based?
Xilio Therapeutics, Inc. is headquartered in Waltham, United States.